Home LiteratureArticle Details
PMID: 2470907 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Low responsiveness to the anti Leu 4 antibody by T cells from patients with active systemic lupus erythematosus.

Journal of clinical & laboratory immunology ·Vol. 28 ·No. 1 ·1989-01-00 ·Pages 15-26

Kaneoka H, Morito F, Yamaguchi M

Abstract

It has been widely accepted that murine monoclonal antibodies against the CD 3 antigen have mitogenic effects on human T cells which mimic antigen binding via the T cell receptors. We report that T cells from patients with active systemic lupus erythematosus cannot respond to anti Leu 4 antibody, an anti CD 3 murine monoclonal antibody of the subclass IgG1. It was observed that T cells from patients with the active disease expressed as much of the Leu 4 and OKT 3 epitopes as compared to high responders, and sera from active patients could not change the expression of the Leu 4 epitope. Similarly, the low responsiveness could not be attributed to suppressor T cells, poor production of IL 2 or less expression of the IL 2 receptor. The accessory nonrosetting mononuclear leucocytes from high responders could convert the low responsiveness of these patients to high, whereas the accessory cells from active patients failed to help the responses of T cells from high responders. Likewise, exogenous IL 1 and anti Leu 4 antibody bound to Sepharose beads independently or cooperatively failed to propagate T cells from low responders. We suggest that the low response to anti Leu 4 antibody as demonstrated in the T cells of patients with active SLE may be due in part to the impairment of the secondary signals, distinct from IL 1, between helping accessory cells and responding T cells, or to the dysfunction of intracellular transmission of stimulation, and may play significant roles in the pathogenesis of SLE.

MeSH Terms
Antibodies, Monoclonal Antigen-Presenting Cells/immunology Antigens, Differentiation, T-Lymphocyte/immunology CD3 Complex Epitopes Female Humans Interleukin-2/pharmacology Kinetics Lupus Erythematosus, Systemic/immunology Lymphocyte Activation/drug effects Male Receptors, Antigen, T-Cell/immunology T-Lymphocytes/immunology T-Lymphocytes, Regulatory/immunology
Chemicals
Antibodies, Monoclonal Antigens, Differentiation, T-Lymphocyte CD3 Complex Epitopes Interleukin-2 Receptors, Antigen, T-Cell
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Kaneoka H
Department of Internal Medicine, Saga Medical School, Japan.
Morito F
Yamaguchi M
Article Info
Journal
Journal of clinical & laboratory immunology
Abbr.
J Clin Lab Immunol
ISSN
0141-2760
Published
1989-01-00
Pages
15-26
Language
English
Region
Scotland
NLM ID
7808987
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]